THERANEXUS SADIR (ALTHX.PA) Stock Overview
EPA:ALTHX - FR0013286259 - Common Stock
ALTHX.PA Key Statistics, Chart & Performance
The current stock price of ALTHX.PA is 2.57 EUR. In the past month the price decreased by -4.81%. In the past year, price increased by 300.31%.
ALTHX.PA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 1LLY.MI | ELI LILLY & CO | 45.25 | 593.15B | ||
| LLY.DE | ELI LILLY & CO | 45.19 | 592.39B | ||
| ZEG.DE | ASTRAZENECA PLC | 18.01 | 422.60B | ||
| JNJ.DE | JOHNSON & JOHNSON | 17.55 | 362.74B | ||
| RHO.DE | ROCHE HOLDING AG-BR | 13.95 | 237.11B | ||
| NOV.DE | NOVO NORDISK A/S-B | 14.34 | 212.86B | ||
| NOT.DE | NOVARTIS AG-REG | 14.45 | 209.73B | ||
| 1SAN.MI | SANOFI | 11.31 | 208.24B | ||
| SAN.PA | SANOFI | 11.19 | 206.07B | ||
| SNW.DE | SANOFI | 11.19 | 206.02B | ||
| 1MRKX.MI | MERCK & CO. INC. | 11.08 | 182.59B | ||
| 6MK.DE | MERCK & CO. INC. | 10.82 | 178.34B |
Related stock screener links
About ALTHX.PA
Company Profile
Theranexus SA engages in the design and development of drug candidates affecting the interaction between neurons and glial cells. The company is headquartered in Lyon, Auvergne-Rhone-Alpes and currently employs 10 full-time employees. The company went IPO on 2017-10-30. The firm is a biopharmaceutical entity that develops drug candidates to be used in the treatment of central nervous system (CNS) disorders, including epilepsy, narcolepsy, Parkinson's disease, Alzheimer's disease, neuropathic pain and psychiatric disorders. Its patented technology is aimed at increasing the efficacy of CNS drugs, which are approved and available on the market. The firm's technology is protected, scalable and versatile, and used to generate high value-added proprietary drug candidates for different conditions, while reducing time-to-market and market entry costs and risks in comparison with standard drug development processes. Theranexus SA operates in the domestic market.
Company Info
THERANEXUS SADIR
60, Avenue Rockefeller - Pepiniere Laennec
Lyon AUVERGNE-RHONE-ALPES FR
Employees: 12
Phone: 33188897031
THERANEXUS SADIR / ALTHX.PA FAQ
What is the stock price of THERANEXUS SADIR today?
The current stock price of ALTHX.PA is 2.57 EUR. The price increased by 7.08% in the last trading session.
What is the ticker symbol for THERANEXUS SADIR stock?
The exchange symbol of THERANEXUS SADIR is ALTHX and it is listed on the Euronext Paris - Matif exchange.
On which exchange is ALTHX.PA stock listed?
ALTHX.PA stock is listed on the Euronext Paris - Matif exchange.
What is the price forecast or stock price prediction for THERANEXUS SADIR stock?
9 analysts have analysed ALTHX.PA and the average price target is 5 EUR. This implies a price increase of 94.47% is expected in the next year compared to the current price of 2.57. Check the THERANEXUS SADIR stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is THERANEXUS SADIR worth?
THERANEXUS SADIR (ALTHX.PA) has a market capitalization of 19.94M EUR. This makes ALTHX.PA a Nano Cap stock.
How many employees does THERANEXUS SADIR have?
THERANEXUS SADIR (ALTHX.PA) currently has 12 employees.
What are the support and resistance levels for THERANEXUS SADIR (ALTHX.PA) stock?
THERANEXUS SADIR (ALTHX.PA) has a support level at 2.56 and a resistance level at 2.61. Check the full technical report for a detailed analysis of ALTHX.PA support and resistance levels.
Should I buy THERANEXUS SADIR (ALTHX.PA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ALTHX.PA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ALTHX.PA, evaluating the profitability, health, valuation and growth aspects
- THERANEXUS SADIR (ALTHX.PA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- THERANEXUS SADIR (ALTHX.PA) Sales and EPS estimates to see what analysts future expectations are.
- THERANEXUS SADIR (ALTHX.PA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- THERANEXUS SADIR (ALTHX.PA) Insider and Institutional Ownership to learn about the owners and their transactions.
- THERANEXUS SADIR (ALTHX.PA) Stock Chart to make your own analysis
- THERANEXUS SADIR (ALTHX.PA) Latest news and press-releases to stay up to date.
Does THERANEXUS SADIR (ALTHX.PA) stock pay dividends?
ALTHX.PA does not pay a dividend.
When does THERANEXUS SADIR (ALTHX.PA) report earnings?
THERANEXUS SADIR (ALTHX.PA) will report earnings on 2025-09-25.
What is the Price/Earnings (PE) ratio of THERANEXUS SADIR (ALTHX.PA)?
THERANEXUS SADIR (ALTHX.PA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.4).
ALTHX.PA Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to ALTHX.PA. When comparing the yearly performance of all stocks, ALTHX.PA is one of the better performing stocks in the market, outperforming 99.5% of all stocks.
ALTHX.PA Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to ALTHX.PA. ALTHX.PA may be in some trouble as it scores bad on both profitability and health.
ALTHX.PA Financial Highlights
Over the last trailing twelve months ALTHX.PA reported a non-GAAP Earnings per Share(EPS) of -0.4. The EPS increased by 68.48% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -72.26% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
ALTHX.PA Forecast & Estimates
9 analysts have analysed ALTHX.PA and the average price target is 5 EUR. This implies a price increase of 94.47% is expected in the next year compared to the current price of 2.57.